Retraction Note: Neuroprotective effect of Buyang Huanwu Decoction on spinal ischemia-reperfusion injury in rats is linked with inhibition of cyclin-dependent kinase 5
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2662-7671
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Retraction Note: Neuroprotective effect of Buyang Huanwu Decoction on spinal ischemia-reperfusion injury in rats is linked with inhibition of cyclin-dependent kinase 5 ; volume:22 ; number:1 ; day:13 ; month:10 ; year:2022 ; pages:1 ; date:12.2022
BMC complementary medicine and therapies ; 22, Heft 1 (13.10.2022), 1, 12.2022
- Creator
-
Wang, Lei
Jiang, Dian-Ming
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12906-022-03750-7
- URN
-
urn:nbn:de:101:1-2022123021220663239441
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:20 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Wang, Lei
- Jiang, Dian-Ming
- SpringerLink (Online service)
Other Objects (12)
Neuroprotective effect of Buyang Huanwu Decoction on spinal ischemia-reperfusion injury in rats is linked with inhibition of cyclin-dependent kinase 5
Cyclin-dependent kinases
Cyclin-dependent kinases and rare developmental disorders
Cyclin-dependent kinases and CDK inhibitors in virus-associated cancers
Activation of cyclin-dependent kinase 5 mediates orofacial mechanical hyperalgesia
Cyclin-dependent kinase 5 mediates pleiotrophin-induced endothelial cell migration
TRAILblazing: cyclin-dependent kinase 9 (CDK9) as target in pancreatic cancer
Cancer therapy by cyclin-dependent kinase inhibitors (CDKIs) : bench to bedside
Mitotic p21Cip1/CDKN1A is regulated by cyclin-dependent kinase 1 phosphorylation
Proteomic profiling reveals that ESR1 mutations enhance cyclin-dependent kinase signaling
The Cyclin-dependent kinase 1: more than a cell cycle regulator
Targeting cyclin-dependent kinases for the treatment of pulmonary arterial hypertension
Neuroprotective effect of Buyang Huanwu Decoction on spinal ischemia-reperfusion injury in rats is linked with inhibition of cyclin-dependent kinase 5
Cyclin-dependent kinases
Cyclin-dependent kinases and rare developmental disorders
Cyclin-dependent kinases and CDK inhibitors in virus-associated cancers
Activation of cyclin-dependent kinase 5 mediates orofacial mechanical hyperalgesia
Cyclin-dependent kinase 5 mediates pleiotrophin-induced endothelial cell migration
TRAILblazing: cyclin-dependent kinase 9 (CDK9) as target in pancreatic cancer
Cancer therapy by cyclin-dependent kinase inhibitors (CDKIs) : bench to bedside
Mitotic p21Cip1/CDKN1A is regulated by cyclin-dependent kinase 1 phosphorylation
Proteomic profiling reveals that ESR1 mutations enhance cyclin-dependent kinase signaling
The Cyclin-dependent kinase 1: more than a cell cycle regulator
Targeting cyclin-dependent kinases for the treatment of pulmonary arterial hypertension
Neuroprotective effect of Buyang Huanwu Decoction on spinal ischemia-reperfusion injury in rats is linked with inhibition of cyclin-dependent kinase 5
Cyclin-dependent kinases
Cyclin-dependent kinases and rare developmental disorders
Cyclin-dependent kinases and CDK inhibitors in virus-associated cancers
Activation of cyclin-dependent kinase 5 mediates orofacial mechanical hyperalgesia
Cyclin-dependent kinase 5 mediates pleiotrophin-induced endothelial cell migration
TRAILblazing: cyclin-dependent kinase 9 (CDK9) as target in pancreatic cancer
Cancer therapy by cyclin-dependent kinase inhibitors (CDKIs) : bench to bedside
Mitotic p21Cip1/CDKN1A is regulated by cyclin-dependent kinase 1 phosphorylation
Proteomic profiling reveals that ESR1 mutations enhance cyclin-dependent kinase signaling
The Cyclin-dependent kinase 1: more than a cell cycle regulator